Who
Vincent Paul Liptak
General Counsel
Company insider
Files Form 4 as: General Counsel, BlossomHill Therapeutics.
In numbers
- Trades disclosed
- 10
- Buys
- 2
- Sells
- 0
- Bought
- $149K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 6 Aug 2026
- Last trade
- 10 Aug 2026
- Last filed
- 10 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill TherapeuticsBiotechnology | SEC FORM 4 Bought | $35K2,200 at $16.00 | filing |
| 10 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill TherapeuticsBiotechnology | SEC FORM 4 Code C | —22,687 | filing |
| 10 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —22,687 | filing |
| 10 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —22,687 | filing |
| 10 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill TherapeuticsBiotechnology | SEC FORM 4 Bought | $35K2,200 at $16.00 | filing |
| 10 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill TherapeuticsBiotechnology | SEC FORM 4 Code C | —22,687 | filing |
| 7 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill TherapeuticsBiotechnology | SEC FORM 4 Bought | $40K2,500 at $15.80 | filing |
| 7 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill TherapeuticsBiotechnology | SEC FORM 4 Bought | $40K2,500 at $15.80 | filing |
| 6 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —46,561 at $0.00 | filing |
| 6 Aug 2026filed 10 Aug 2026 | BLSM BlossomHill Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —46,561 at $0.00 | filing |
News
BlossomHill Therapeutics Announces Collaboration with Foundation Medicine to Develop First Companion Diagnostic for BH-30643 in EGFR C797S Mutated Non-Small Cell Lung CancerBLSM · manilatimes.net · 22 Oct 2026
0 headlines in the last 90 days name Vincent Paul Liptak; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.